Mark Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs
June 17 (Reuters) - Telehealth firm 9amHealth has partnered with billionaire entrepreneur Mark Cuban's Cost Plus Drug Company to offer U.S. employers cheaper obesity treatment options, the companies said on Tuesday.
Cost Plus Drugs supplies generic drugs by contracting directly with manufacturers and applying a standard markup on each drug it sells.
Employees will now have access to affordable medications through Cost Plus Drugs, supported by 9amHealth's team of doctors, all without long waits or costly appointments.
The two companies will offer an option for employers looking to enhance coverage for weight management as well as chronic conditions such as diabetes, high cholesterol and hypertension.
Cuban's startup offers a generic version of Novo Nordisk's (NOVOb.CO), opens new tab older GLP-1 diabetes drug, Victoza, in injectable form, according to its website.
Additionally, 9amHealth's obesity program includes branded GLP-1 medications available through direct manufacturer partnerships.
Cost Plus Drugs and 9amHealth did not immediately respond to Reuters' requests for comment on what drugs the tie-up will make available.
Newer weight-loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's (LLY.N), opens new tab Zepbound, known to reduce weight by as much as 20%, can cost up to $1,000 per month without insurance coverage.
Cost Plus Drugs has also established similar tie-ups with pharmacy benefit managers RxPreffered and AffirmedRx to provide lower-priced drugs via some employer-backed health insurance plans.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
39 minutes ago
- The Independent
EPA will revisit Biden-era ban on the last type of asbestos used in US
The Environmental Protection Agency told a federal appeals court it will reconsider the Biden administration's ban on the last type of asbestos used in the United States to determine whether it went 'beyond what is necessary." Asbestos is linked to tens of thousands of deaths annually and causes mesothelioma as well as other cancers. It has been largely phased out in the United States. Last year, the Biden administration sought to finish the decades-long fight by banning chrysotile asbestos. At the time, the EPA called it a milestone in the fight against cancer. The EPA on Monday said in a court filing that it would reconsider the Biden administration's rule over roughly the next 30 months. The agency said the Toxic Substances Control Act requires it to evaluate a chemical's risk and the consequences of restricting it. Now, officials will look at whether parts of the ban 'went beyond what is necessary to eliminate the unreasonable risk and whether alternative measures — such as requiring permanent workplace protection measures — would eliminate the unreasonable risk,' according to a court declaration by Lynn Ann Dekleva, a senior official in EPA's Office of Chemical Safety and Pollution Prevention. Chrysotile asbestos is found in products like brake blocks, asbestos diaphragms and sheet gaskets and was banned under the Toxic Substances Control Act, which was broadened in 2016. When the ban was announced, there were eight U.S. facilities that used asbestos diaphragms in the chlor-alkali sector for the manufacture of chlorine and sodium hydroxide, chemicals commonly used as water disinfectants. The facilities were given at least five years to make the change. The development was first reported by The New York Times. Advocates blasted the move as weakening prohibitions against a deadly carcinogen. 'This latest move by Administrator Lee Zeldin and EPA is yet another alarming signal that this administration is operating without limits as they dole out favors to polluter lobbyists without regard for the health and well-being of people living in the US,' said Michelle Roos, executive director of the Environmental Protection Network, a nonprofit. Zeldin has announced dozens of deregulatory actions in the first months of the Trump administration and former top industry officials are in key EPA positions — Dekleva, for example, used to work at the American Chemistry Council, which was among the groups that filed the court challenge against the Biden administration's ban. Recently, the EPA proposed a rollback of greenhouse gas rules for coal plants. The EPA did not immediately respond to a request for comment late Tuesday. ___
The Independent
an hour ago
- The Independent
Kristi Noem rushed to hospital in an ambulance after allergic reaction, DHS says
Homeland Security Secretary Kristi Noem was rushed to a hospital in Washington, D.C. on Tuesday after experiencing an allergic reaction, according to an agency spokesperson. 'Secretary Noem had an allergic reaction today,' DHS assistant secretary Tricia McLaughlin said in a statement to The Independent. 'She was transported to the hospital out of an abundance of caution. She is alert and recovering,' she added. Noem has been conscious and has been speaking with her security detail, according to CNN, citing sources familiar with the matter. This is a developing story
Telegraph
an hour ago
- Telegraph
Kristi Noem rushed to hospital
Kristi Noem, Donald Trump's homeland security secretary, has been rushed to hospital, according to reports. Ms Noem was taken to hospital in Washington, DC by ambulance, two sources familiar with the matter told CNN. Details of her condition are unclear. Ms Noem is said to have been conscious at the hospital and has reportedly spoken with her security team. The Telegraph has approached the DHS for comment.
